German court upholds cancer treatment award
A Taiwanese pharmaceuticals company has failed to overturn an award in a billion-euro ICC dispute over a blood cancer drug based on allegations it was not allowed to fully defend itself.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10